No description
-
1991 (v1)PublicationUploaded on: April 14, 2023
-
2007 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2006 (v1)Publication
No description
Uploaded on: March 31, 2023 -
1991 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2003 (v1)Publication
No description
Uploaded on: April 14, 2023 -
1993 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2002 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2003 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2007 (v1)Publication
No description
Uploaded on: March 31, 2023 -
1995 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2000 (v1)Publication
No description
Uploaded on: April 14, 2023 -
1993 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2000 (v1)Publication
No description
Uploaded on: April 14, 2023 -
1992 (v1)Publication
No description
Uploaded on: April 14, 2023 -
1996 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2011 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2016 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2006 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2000 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2006 (v1)Publication
No description
Uploaded on: April 14, 2023 -
1993 (v1)Publication
No description
Uploaded on: April 14, 2023 -
1999 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2002 (v1)Publication
No description
Uploaded on: December 4, 2022 -
2007 (v1)Publication
CONTEXT: Criteria to define the response to somatostatin (SS) analogs (SSA) in acromegaly are based on biochemical control of the disease. However, the mechanisms of action of SSAs in inhibiting tumor growth and hormonal secretion are only partially understood, and the two effects may occur independently. OBJECTIVE: The objective of the study...
Uploaded on: March 31, 2023